Abstract:Xiudan Li, 1, 2 Lifeng Gao, 2 Xuyang Li, 2 Jingdong Xia, 1 Yurong Pan, 1 Chunying Bai 2 1 Department of Endocrinology, Affiliated Hospital of Chifeng University, Chifeng, 024000, China; 2 Inner Mongolia Key Laboratory of Human Genetic Disease Research, Chifeng University, Chifeng, 024000, China Correspondence: Chunying Bai, Email Diabetic nephropathy (DN) is one of the most common microvascular complications in diabetes and can potentially develop into end-stage renal disease. Its pathogenesis is complex and not fully understood. Podocytes, glomerular endothelial cells (GECs), glomerular mesangial cells (GMCs) and renal tubular epithelial cells (TECs) play important roles in the normal function of glomerulus and renal tubules, and their injury is involved in the progression of DN. Although our understanding of the mechanisms leading to DN has substantially improved, we still need to find more effective therapeutic targets. Autophagy, pyroptosis and ferroptosis are programmed cell death processes that are associated with inflammation and are closely related to a variety of diseases. Recently, a growing number of studies have reported that autophagy, pyroptosis and ferroptosis regulate the function of podocytes, GECs, GMCs and TECs. This review highlights the contributions of autophagy, pyroptosis, and ferroptosis to DN injury in these cells, offering potential therapeutic targets for DN treatment. Keywords: diabetic nephropathy, autophagy, pyroptosis, ferroptosis, inflammation With the development of society and changes in lifestyle, the prevalence of diabetes has been steadily rising in recent years. 1,2 The statistics from the International Diabetes Federation show that in 2021, the number of diabetic patients worldwide reached 536 million. 3 The prevalence of diabetic complications is also increasing. As one of the most common microvascular complications of diabetes, the prevalence of diabetic nephropathy (DN) in the late stages of diabetes is almost 50%. 4,5 Due to these trends, DN has become a serious public health problem in the world. 6 DN is a complex and chronic disease characterized by glomerular hyperfiltration, hyperperfusion, thickening of the glomerular basement membrane, glomerular capillary injury, mesangial expansion, and microalbuminuria. 7,8 In the early stages of DN, the volume of the kidney increases and the glomerular filtration rate increases. As the disease progresses to the middle stages, the basement membrane thickens and the mesangial matrix increases. This leads to glomerular nodular and diffuse lesions, arteriolar hyaline degeneration, further thickening of the glomerular basement membrane, and progressive stenosis of the glomerular capillary cavity. In the late stages, glomerular and tubulointerstitial fibrosis occurs, resulting in glomerular atrophy and ultimately renal failure. Multiple studies have shown that the regulation of inflammation, endoplasmic reticulum stress (ERS), oxidative stress and other related proteins plays crucial roles in the progression of DN. 8–13 Furthermore, certain regulatory factors can promote the transformation of endothelial cells into mesenchymal cells, a process known as epithelial-mesenchymal transition (EMT). This process plays a significant role in the development of renal fibrosis in DN. Additionally, recent studies have highlighted the dysfunction of cell junction proteins in podocytes, glomerular endothelial cells (GECs), glomerular mesangial cells (GMCs), and renal tubular epithelial cells (TECs) as key players in DN pathogenesis. 14–17 Despite ongoing research, the pathogenesis of DN remains incompletely understood due to its complexity. Therefore, elucidating the underlying mechanisms of DN and identifying therapeutic targets have both emerged as crucial strategies for effective DN treatment. Autophagy, an intracellular degradation process, plays a pivotal role in maintaining cellular homeostasis. 18,19 It is involved in the pathogenesis of numerous diseases, including diabetes, 20 DN, 9 and cardiovascular disease. 19 Pyroptosis, a distinct form of programmed cell death, differs from apoptosis both morphologically and mechanistically. It is characterized by the formation of inflammasomes and the production of pro-inflammatory caspases. 21–23 Pyroptosis has been implicated in a range of diseases, including atherosclerosis, diabetes, and DN. 10,24 Ferroptosis, another type of programmed cell death, is characterized by iron-dependent accumulation of lipid hydroperoxides to lethal levels. 25 The role of inflammation in the onset and progression of DN is well-documented. 7,12 Inflammation markers -Abstract Truncated-

Profilin1 Promotes Renal Tubular Epithelial Cell Apoptosis in Diabetic Nephropathy Through the Hedgehog Signaling Pathway

Downregulation of Profilin-1 Expression Attenuates Cardiomyocytes Hypertrophy and Apoptosis Induced by Advanced Glycation End Products in H9c2 Cells

CDKN2B-AS1 participates in high glucose-induced apoptosis and fibrosis via NOTCH2 through functioning as a miR-98-5p decoy in human podocytes and renal tubular cells

[Down-regulation of PHLPP1 expression ameliorates high glucose-induced autophagy inhibition and apoptosis promotion of podocytes by activating PI3K/AKT/mTOR pathway]

Profilin1 is required for prevention of mitotic catastrophe in murine and human glomerular diseases

Apoc1 Knockdown Alleviates High Glucose-induced Oxidative Stress and Apoptosis of Renal Tubular Cells by Binding to Clusterin

CKIP-1 Ameliorates High Glucose-Induced Expression of Fibronectin and Intercellular Cell Adhesion Molecule-1 by Activating the Nrf2/ARE Pathway in Glomerular Mesangial Cells

Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy

HIF-1 alpha Alleviates High-Glucose-Induced Renal Tubular Cell Injury by Promoting Parkin/PINK1-Mediated Mitophagy

HIF-1α Alleviates High-Glucose-Induced Renal Tubular Cell Injury by Promoting Parkin/PINK1-Mediated Mitophagy

Ets1 Associates with KMT5A to Participate in High Glucose-Mediated EndMT Via Upregulation of PFN2 Expression in Diabetic Nephropathy.

FOXP1 Inhibits High Glucose-Induced ECM Accumulation and Oxidative Stress in Mesangial Cells.

Protective Role of PGC-1α in Diabetic Nephropathy is Associated with the Inhibition of ROS Through Mitochondrial Dynamic Remodeling.

Silencing of KPNA2 Inhibits High Glucose-Induced Podocyte Injury Via Inactivation of Mtorc1/p70s6k Signaling Pathway

Identifying the Potential Diagnostic Gene Biomarkers and Forecasting the Potential Therapeutic Agents for Advanced Diabetic Nephropathy Based on Pyroptosis and Ferroptosis

PC-1 NF Suppresses High Glucose-Stimulated Inflammation and Extracellular Matrix Accumulation in Glomerular Mesangial Cells Via the Wnt/β-catenin Signaling.

Paeoniflorin directly binds to TNFR1 to regulate podocyte necroptosis in diabetic kidney disease

Protein arginine methyltranferase-1 induces ER stress and epithelial-mesenchymal transition in renal tubular epithelial cells and contributes to diabetic nephropathy

Autophagy, Pyroptosis and Ferroptosis are Rising Stars in the Pathogenesis of Diabetic Nephropathy

GSDME-dependent pyroptosis signaling pathway in diabetic nephropathy

Identification of Hub Genes Involved in Tubulointerstitial Injury in Diabetic Nephropathy by Bioinformatics Analysis and Experiment Verification